Citrus/Cydonia Compositum Subcutaneous Injections versus Nasal Spray for Seasonal Allergic Rhinitis: A Randomized Controlled Trial on Efficacy and Safety

Background. Clinical experiences in vitro and clinical studies have demonstrated the curative potency and safety of Citrus/Cydonia compositum in seasonal allergic rhinitis treatment. Objectives. To compare the efficacy and safety of two routes of administration (nasal spray versus subcutaneous injections). Methodology: Design. a national, randomised, comparative clinical trial with two parallel groups. Participants. 23 patients fulfilled the study requirements. Intervention. after a one- or two-week wash-out period, 23 patients were randomized, to a 6-week treatment period. Outcomes. immunological and symptom severity changes and safety. Immunologic outcome assessments were blinded to group assignment. 23 patients were randomized and from 22/23 patients (11 in each group) blood samples were analyzed before and after treatment. Conclusion. Both routes of administration demonstrate immunological and clinical effects, with larger inflammatory and innate immunological effects of the nasal spray route and larger allergen-specific clinical effects of the subcutaneous route, and are safe.

[1]  V. Mersch-Sundermann,et al.  Immunomodulatory properties of a lemon-quince preparation (Gencydo®) as an indicator of anti-allergic potency. , 2011, Phytomedicine : international journal of phytotherapy and phytopharmacology.

[2]  A. Kant.  Dietary patterns: biomarkers and chronic disease risk. , 2010, Applied physiology, nutrition, and metabolism = Physiologie appliquee, nutrition et metabolisme.

[3]  T. Jakob,et al.  Birch Pollen Immunotherapy Leads to Differential Induction of Regulatory T Cells and Delayed Helper T Cell Immune Deviation , 2010, The Journal of Immunology.

[4]  T. Deraz.  Immunopathogenesis of allergic rhinitis , 2010 .

[5]  B. Samoliński,et al.  Prevalence of rhinitis in Polish population according to the ECAP (Epidemiology of Allergic Disorders in Poland) study. , 2009, Otolaryngologia polska = The Polish otolaryngology.

[6]  C. Akdis,et al.  T regulatory cells and their counterparts: masters of immune regulation , 2009, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

[7]  C. Akdis,et al.  Mechanisms and treatment of allergic disease in the big picture of regulatory T cells. , 2009, The Journal of allergy and clinical immunology.

[8]  H. Kumagami,et al.  Relationship between airborne pollen count and treatment outcome in Japanese cedar pollinosis patients , 2009, European Archives of Oto-Rhino-Laryngology.

[9]  H. Savelkoul,et al.  Citrus/Cydonia Comp. Can Restore the Immunological Balance in Seasonal Allergic Rhinitis-Related Immunological Parameters In Vitro , 2008, Mediators of inflammation.

[10]  Claudia Rother.  Untersuchung zur Ermittlung des Anwendungsnutzens von Weleda Heuschnupfenspray unter besonderer Berücksichtigung der Wirkungsdynamik − Ergebnisse einer prospektiven Beobachtungsstudie , 2008 .

[11]  H. Savelkoul,et al.  T cell responses in fresh and cryopreserved peripheral blood mononuclear cells: kinetics of cell viability, cellular subsets, proliferation, and cytokine production. , 2008, Cryobiology.

[12]  P. Avila,et al.  Advances in upper airway diseases and allergen immunotherapy in 2007. , 2008, The Journal of allergy and clinical immunology.

[13]  B. Bohle.  The impact of pollen‐related food allergens on pollen allergy , 2007, Allergy.

[14]  E. Baars,et al.  The effect of Gencydo injections on hayfever symptoms: a therapeutic causality report. , 2005, Journal of alternative and complementary medicine.

[15]  H. Nelson.  Advances in upper airway diseases and allergen immunotherapy. , 2003, The Journal of allergy and clinical immunology.

[16]  Jeannine S. Schiller,et al.  Summary health statistics for U.S. adults: National Health Interview Survey, 2002. , 2004, Vital and health statistics. Series 10, Data from the National Health Survey.

[17]  C. Akdis,et al.  Immune Responses in Healthy and Allergic Individuals Are Characterized by a Fine Balance between Allergen-specific T Regulatory 1 and T Helper 2 Cells , 2004, The Journal of experimental medicine.

[18]  Sergio Romagnani,et al.  Immunologic influences on allergy and the TH1/TH2 balance. , 2004, The Journal of allergy and clinical immunology.

[19]  S. Gabrielsson,et al.  Specific induction of interleukin‐4‐producing cells in response to in vitro allergen stimulation in atopic individuals , 1997, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

[20]  N. Najafian,et al.  Nonallergic individuals recognize the same T cell epitopes of Bet v 1, the major birch pollen allergen, as atopic patients. , 1995, Journal of immunology.

[21]  K. Tracey,et al.  Tumor necrosis factor, other cytokines and disease. , 1993, Annual review of cell biology.

[22]  K. Nakagomi,et al.  Inhibitory effects of pectic substances on activated hyaluronidase and histamine release from mast cells. , 1992, Biochimica et biophysica acta.